There is a need to carefully control the size of the CD4+CD25high regulatory T cell population in vivo to achieve a balance between the necessity to suppress auto-reactivity and the ability to allow appropriate responses to foreign and tumor antigens. The gene discussed is CD4; the disease is neoplasm.